Pekin Hardy Strauss, Inc. Charles River Laboratories International, Inc. Transaction History
Pekin Hardy Strauss, Inc.
- $785 Million
- Q1 2025
A detailed history of Pekin Hardy Strauss, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pekin Hardy Strauss, Inc. holds 23,395 shares of CRL stock, worth $3.39 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
23,395Holding current value
$3.39 Million% of portfolio
0.45%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$886 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$738 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$622 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$347 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$283 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.38B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...